Free Trial

Canopy Growth (CGC) Stock Forecast & Price Target

$8.48
-0.70 (-7.63%)
(As of 05/28/2024 ET)

Canopy Growth - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
Based on 3 Analyst Ratings

Consensus Price Target

$4.87
-42.61% Downside
High Forecast$6.60
Average Forecast$4.87
Low Forecast$3.00
TypeCurrent Forecast
5/29/23 to 5/28/24
1 Month Ago
4/29/23 to 4/28/24
3 Months Ago
2/28/23 to 2/28/24
1 Year Ago
5/29/22 to 5/29/23
Consensus Rating
Sell
Reduce
Reduce
Hold
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
0 Buy rating(s)
0 Buy rating(s)
0 Buy rating(s)
3 Buy rating(s)
Hold
1 Hold rating(s)
2 Hold rating(s)
2 Hold rating(s)
5 Hold rating(s)
Sell
2 Sell rating(s)
2 Sell rating(s)
2 Sell rating(s)
3 Sell rating(s)
Consensus Price Target$4.87$4.87$4.87$25.05
Forecasted Upside-42.61% Downside-34.17% Downside-34.17% Downside-19.03% Downside
Get Canopy Growth Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for CGC and its competitors with MarketBeat's FREE daily newsletter.

CGC Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

CGC Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Canopy Growth Stock vs. The Competition

TypeCanopy GrowthMedical CompaniesS&P 500
Consensus Rating Score
1.33
2.70
2.49
Consensus RatingSellModerate BuyHold
Predicted Upside-46.64% Downside836.53% Upside9.93% Upside
News Sentiment RatingPositive News
Positive News
Positive News

Recent Analyst Forecasts and Stock Ratings

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
2/12/2024Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetUnderperform$5.00 ➝ $3.00-21.47%
1/31/2024Sanford C. Bernstein
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetMarket Perform$5.00+3.31%
9/15/2023Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetUnderperform ➝ Underperform$5.60 ➝ $6.60-51.18%
5/1/2023BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeUnderperform ➝ Market Perform
2/17/2023Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetNeutral$33.00 ➝ $32.00+27.49%
2/13/2023Roth Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
W. Kirk
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy
2/10/2023CIBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetC$25.00 ➝ C$17.50
2/9/2023Alliance Global Partners
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetC$45.00 ➝ C$35.00
11/7/2022Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Matt Bottomley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetHold ➝ HoldC$42.50 ➝ C$50.00
9/30/2022Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetUnderweight$35.00 ➝ $20.00-28.06%
6/29/2022MKM Partners
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Bill Kirk
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetBuy ➝ BuyC$170.00 ➝ C$130.00
6/1/2022Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingMarket Perform
5/30/2022Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy$50.00+2.46%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Tuesday at 08:47 PM ET.

CGC Frequently Asked Questions

What is Canopy Growth's stock forecast and purchase recommendation?

According to the research reports of 3 Wall Street equities research analysts, the average twelve-month stock price forecast for Canopy Growth is $4.87, with a high forecast of $6.60 and a low forecast of $3.00. The consensus rating for Canopy Growth stock is Sell based on the current 2 sell ratings and 1 hold rating for CGC. Learn more on CGC's analyst rating history.

Do Wall Street analysts like Canopy Growth more than its competitors?

Analysts like Canopy Growth less than other "medical" companies. The consensus rating for Canopy Growth is Sell while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how CGC compares to other companies.

Does Canopy Growth's stock price have much downside?

According to analysts, Canopy Growth's stock has a predicted downside of -34.17% based on their 12-month stock forecasts.


Stock Forecasts and Research Tools

This page (NASDAQ:CGC) was last updated on 5/28/2024 by MarketBeat.com Staff

From Our Partners